A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content

Journal of Rheumatology

Volumn 29, Issue 1, 2002, Pages 68-74

  Tan, E M ^a   Smolen, J S ^a   McDougal, J S ^a   Fritzler, M J ^a   Gordon, T ^a   Hardin, J A ^a   Kalden, J R ^a   Lahita, R G ^a   Maini, R N ^a   Reeves, W H ^a   Rothfield, N F ^a   Takasaki, Y ^a   Wiik, A ^a   Wilson, M ^a   Koziol, J A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoantibodies; Autoimmunity; Diagnosis; Diagnostic kits

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA;

ANALYTICAL EQUIPMENT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; BIOMEDICAL TECHNOLOGY ASSESSMENT; CALIBRATION; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATIC DISEASE;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DNA; DNA-BINDING PROTEINS; EVALUATION STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; NUCLEAR PROTEINS; REGRESSION ANALYSIS;

EID: 0036137708     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus
2. Immunologic studies concerning the nephritis of systemic lupus erythematosus
3. The relation of immunoglobulin class, pattern of antinuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus
4. Immunologic factors and clinical activity in systemic lupus erythematosus
5. Deoxyribonucleic acid antibody: A method to detect its primary interaction with deoxyribonucleic acid
6. 3H) sulfate
7. Measurement of serum DNA-binding activity in systemic lupus erythematosus
8. Anti-DNA activity in systemic lupus erythematosus
9. The prognostic and therapeutic implications of DNA: Anti-DNA immune complexes in systemic lupus erythematosus
10. Role of DNA-anti-DNA complexes in the immunopathogenesis of tissue injury in systemic lupus erythematosus
11. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus
12. Quantitation and detection of isotypes of anti-SSB antibodies by ELISA and Farr assays using affinity purified antigens
13. Serial estimation of anti-RNP antibody levels in systemic lupus erythematosus, mixed connective tissue disease, and rheumatoid arthritis
14. Quantitation of antibodies to nucleoribonucleoprotein by ELISA: Relation between antibody levels and disease activity in patients with connective tissue diseases
15. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus
16. IgG and IgM anti-snRNP reactivity in sequentially obtained serum samples from patients with connective tissue diseases
17. Changes in anti-UI RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome
18. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting
19. Measurement of antibodies to Sm and nRNP by ELISA: Clinical and serological correlations
20. Use of recombinant RNP-peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: A longitudinal follow up of 18 patients
21. A critical evaluation of enzyme immunoassays for detection of antinuclear antibodies of defined specificities. I. Precision, sensitivity and specificity
22. Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP and SSB/La
23. Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and Western blotting
24. Radioligand assay
25. Calibration and assay development using the four-parameter logistic model
26. Development of the antinuclear and anticytoplasmic antibody consensus panel by the Association of Medical Laboratory Immunologists